A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified August 2012 by University of Kansas
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Joseph Donnelly, University of Kansas
ClinicalTrials.gov Identifier:
NCT01664715
First received: August 10, 2012
Last updated: August 13, 2012
Last verified: August 2012

August 10, 2012
August 13, 2012
August 2012
June 2016   (final data collection date for primary outcome measure)
  • Prevention of Weight Regain [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
    To compare the effectiveness of 3 exercise recommendations on the prevention of weight regain over 12 mos. subsequent to clinically significant weight loss (> 5%). We expect participants will regain weight in a dose-response manner, i.e. greatest, intermediate and least weight regain for the 1,000, 2,000 and 3,000 kcal/wk. groups, respectively.
  • Gender Differences in Weight Regain [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
    To evaluate gender differences in weight regain over 12 months in response to 3 exercise recommendations. Based on available preliminary data we expect men will regain less weight than women.
Same as current
Complete list of historical versions of study NCT01664715 on ClinicalTrials.gov Archive Site
Compensatory Changes to three exercise levels [ Time Frame: 12 Months ] [ Designated as safety issue: No ]
To evaluate the impact of potential compensatory changes in daily physical activity and energy intake on weight regain in response to 3 exercise recommendations. Any observed compensatory responses would inform the development of subsequent targeted interventions.
Same as current
Not Provided
Not Provided
 
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain

The investigators will conduct a randomized trial to evaluate the effectiveness of 3 levels of recommended energy expenditure of exercise (EEEx) in initially overweight and obese sedentary men and women on the prevention of weight regain. Participants will complete a 3 mo. weight loss intervention of decreased energy intake (EI) and increased EEEx (1,000 kcal/wk.), a level of exercise consistent with Health and Human Services (HHS) recommendations. Participants achieving clinically significant weight loss (> 5% of initial weight), will be randomly assigned to 12 mos. of exercise at levels of EEEx recommended by: 1.) HHS, ~1,000 kcal/wk., 2.) American College of Sports Medicine( ACSM),~ 2,000 kcal/wk., 3.) Institute of Medicine (IOM), ~3,000 kcal/wk. Major outcome assessments will occur prior to weight loss (-3 mos.), at completion of weight loss (0 mos.), at the midpoint (6 mos.), and completion of weight maintenance (12 mos).

The investigators propose a randomized trial in 287 overweight and obese, sedentary adults (at least 50% women). Participants achieving clinically significant weight loss (≥5%) following a 3 mo. reduced energy diet and a program of PA (1,000 kcal/wk.) will be randomly assigned to either maintain exercise at 1,000 kcal/wk. or increase exercise to 2,000 or 3,000 kcal/wk. while consuming a weight gain prevention diet over a 12 mo. period. Exercise will be verified (combination of on-site and HR monitor) and EEEx will be measured at 3 mo. intervals beginning at mo. 0 (the end of weight loss). In-person behaviorally based clinic meetings will be conducted weekly during the 3 mo. weight loss period (-3 to 0 mos.) and during the first 3 mos. of the weight regain prevention period. During the final 9 mos. of weight regain prevention, clinics will be held bi-monthly using group conference calls. We have not proposed to randomize participants to a true control group (i.e. no exercise or diet) following the 3 mo. weight loss program as published data indicates significant weight regain in individuals receiving no follow-up treatment after weight loss.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Overweight
  • Obesity
  • Weight Loss
  • Behavioral: 1,000 kcal/wk
    Performs 1,000 kcal/wk of planned moderate intensity aerobic exercise.
  • Behavioral: 2,000 kcal/wk
    Performs 2,000 kcal/wk of planned moderate intensity aerobic exercise.
  • Behavioral: 3,000 kcal/wk
    Performs 3,000 kcal/wk of planned moderate intensity aerobic exercise.
  • Active Comparator: 1,000 kcal/wk
    Performs 1,000 kcal/wk of planned moderate intensity aerobic exercise.
    Intervention: Behavioral: 1,000 kcal/wk
  • Active Comparator: 2,000 kcal/wk
    Performs 2,000 kcal/wk of planned moderate intensity aerobic exercise.
    Intervention: Behavioral: 2,000 kcal/wk
  • Active Comparator: 3,000 kcal/wk
    Performs 3,000 kcal/wk of planned moderate intensity aerobic exercise.
    Intervention: Behavioral: 3,000 kcal/wk
Szabo AN, Washburn RA, Sullivan DK, Honas JJ, Mayo MS, Goetz J, Lee J, Donnelly JE. The Midwest Exercise Trial for the Prevention of Weight Regain: MET POWeR. Contemp Clin Trials. 2013 Nov;36(2):470-8. doi: 10.1016/j.cct.2013.08.011. Epub 2013 Sep 4.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
287
April 2017
June 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 21 to 55 years.
  • BMI of 25 to 39.9.
  • Clearance for participation from their PCP

Exclusion Criteria:

  • Participation in a research project involving weight loss or exercise in the previous 6 mos., as these proximal experiences may impact the results of this study.
  • Participation in a regular exercise program (i.e., > 500 kcal/wk. of planned activity as estimated by questionnaire
  • Not weight stable (+ or - 4.5 kg) for 3 mos. prior to intake.
  • Unwilling to be randomized to 1 of 3 exercise groups subsequent to weight loss.
  • Pregnant during the previous 6 mos., lactating, or planned pregnancy in the following 15 mos.
  • Serious medical risk such as type 1 diabetes, cancer, recent cardiac event (i.e., heart attack, angioplasty, etc.). This is determined by the individual's physician via the clearance to participate in the investigation and the health history (Appendix) interpreted by the staff physician.
  • Eating disorders as determined by the Eating Attitudes Test using a score of 20 or greater
  • Current treatment for psychological problems, or taking psychotropic medications
  • Medications known to significantly affect weight (gain or loss).
  • Adherence to specialized diet regimens, i.e., multiple food allergies, vegetarian, macrobiotic, etc.
  • Do not have access to grocery shopping and meal preparation (i.e. those in military, college with cafeteria plan, etc.).
Both
21 Years to 55 Years
No
Contact: Jeff Honas 785-864-4163 jhonas@ku.edu
United States
 
NCT01664715
HSCL19775, R01HL111842
Yes
Joseph Donnelly, University of Kansas
University of Kansas
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Joseph Donnelly, EdD University of Kansas
University of Kansas
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP